CN116507221A - 在性交后膀胱炎中使用具有益生菌作用的乳酸菌、蔓越莓提取物和d-甘露糖的组合 - Google Patents

在性交后膀胱炎中使用具有益生菌作用的乳酸菌、蔓越莓提取物和d-甘露糖的组合 Download PDF

Info

Publication number
CN116507221A
CN116507221A CN202180073348.1A CN202180073348A CN116507221A CN 116507221 A CN116507221 A CN 116507221A CN 202180073348 A CN202180073348 A CN 202180073348A CN 116507221 A CN116507221 A CN 116507221A
Authority
CN
China
Prior art keywords
post
mannose
cystitis
coital
lactic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180073348.1A
Other languages
English (en)
Chinese (zh)
Inventor
斯蒂凡诺·哥伦布
安娜·波尔切蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mamma Pharmaceutical Co
Original Assignee
Mamma Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mamma Pharmaceutical Co filed Critical Mamma Pharmaceutical Co
Publication of CN116507221A publication Critical patent/CN116507221A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202180073348.1A 2020-11-06 2021-10-27 在性交后膀胱炎中使用具有益生菌作用的乳酸菌、蔓越莓提取物和d-甘露糖的组合 Pending CN116507221A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102020000026518A IT202000026518A1 (it) 2020-11-06 2020-11-06 Uso di una combinazione di fermenti lattici vivi ad azione probiotica, estratto di mirtillo rosso e d-mannosio nella cistite post coitale
IT102020000026518 2020-11-06
PCT/EP2021/079770 WO2022096336A1 (en) 2020-11-06 2021-10-27 Use of a combination of lactic acid bacteria with probiotic action, cranberry extract and d-mannose for prevention of post coital cystitis

Publications (1)

Publication Number Publication Date
CN116507221A true CN116507221A (zh) 2023-07-28

Family

ID=74194976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180073348.1A Pending CN116507221A (zh) 2020-11-06 2021-10-27 在性交后膀胱炎中使用具有益生菌作用的乳酸菌、蔓越莓提取物和d-甘露糖的组合

Country Status (3)

Country Link
CN (1) CN116507221A (it)
IT (1) IT202000026518A1 (it)
WO (1) WO2022096336A1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906109B1 (fr) * 2006-09-22 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire pour la prevention et la lutte contre les infections urinaires
US20110064706A1 (en) * 2008-01-11 2011-03-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.

Also Published As

Publication number Publication date
WO2022096336A1 (en) 2022-05-12
IT202000026518A1 (it) 2022-05-06

Similar Documents

Publication Publication Date Title
Kurbonalievich et al. Experience of the Combination of Tiflox and Immunomax in the Treatment of Trichomoniasis Combined with a Bacterial Process
Beyitler et al. Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature
Komala et al. Urinary tract infection: causes, symptoms, diagnosis and it's management
Madersbacher et al. Conservative management in neuropathic urinary incontinence
Bahadi et al. Urinary tract infection in pregnancy
JPH06501937A (ja) 非炎症性及び非感染性腸障害の処置
CN116507221A (zh) 在性交后膀胱炎中使用具有益生菌作用的乳酸菌、蔓越莓提取物和d-甘露糖的组合
Sarkisova et al. INFLAMMATORY DISEASES OF THE PELVIC WOMEN ORGANS
KR101122703B1 (ko) 코골이 개선 및 예방용 조성물
Bleicher et al. Association between recurrent bacterial vaginosis and Helicobacter pylori infection: a case report
RU2361595C1 (ru) Способ лечения осложненного урогенитального хламидиоза
Zhabborova et al. Mechanisms of local immunity of the oral mucosa in coronavirus infection
Shukla et al. CYSTOCRAN Tablet: A Natural Antibiotic Safeguard in Urinary Tract Infections
Shukla et al. CYSTOCRAN Tablets: A Natural Antibacterial Safeguard in UTI Infections
Olena et al. EXPERIENCE IN THE USE OF PROBIOTICS FOR THE PREVENTION OF VAGINAL DYSBIOSIS IN WOMEN OF REPRODUCTIVE AGE
Glass et al. Consultation/Referral
Faraz et al. Urinary tract infections in women: Treatment options and antibiotic resistance
Soyer et al. Acute urinary retention due to pseudoephedrine hydrochloride in a 3-year-old child
Abdulsamad et al. RECURRENT URINARY TRACT INFECTION IN THE FEMALE
EP3496731B1 (en) Composition for the treatment of pathologies of the urinary system
Sunny Effect of complementary alternative medicine on menopausal symptoms, among rural women of South India
O'Riordan et al. Management of recurrent urinary tract infections in adults
Glass et al. Urinary Incontinence (UI)
NOI AGHIL KATTAI CHOORANAM
JP2007518797A (ja) 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40100059

Country of ref document: HK